VNDA icon

Vanda Pharmaceuticals
VNDA

Overview Fund Trends Analyst Outlook Journalist POV

109 hedge funds and large institutions have $571M invested in Vanda Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 32 increasing their positions, 34 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

6% less repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 34

Holders
109
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$56.9M
Puts
$13.2M
Net Calls
Net Calls Change

Top Buyers

1
+$22.6M
2
+$18.2M
3
+$16.6M
4
State Street
State Street
Massachusetts
+$16.1M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$8.83M

Top Sellers

1
-$11M
2
-$10.2M
3
-$8.92M
4
O
OrbiMed
New York
-$8.57M
5
BBA
Baker Bros. Advisors
New York
-$5.61M
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$3.91M
27
$3.66M
28
$3.59M
29
$3.49M
30
$3.38M
31
$3.36M
32
$3.25M
33
$3.09M
34
$3.08M
35
$2.92M
36
$2.76M
37
$2.6M
38
$2.44M
39
$2.38M
40
$2.25M
41
$2.05M
42
$2M
43
$1.81M
44
$1.78M
45
$1.63M
46
$1.58M
47
$1.49M
48
$1.49M
49
$1.33M
50
$1.21M
1
2
3 4 5